Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies

Figure 3

Typical inorganic nanomaterials under investigation for various biomedical applications such as the localized delivery of drugs. (a) Porous silicon nanoparticles from Secret et al. 2013 [37], (b) mesoporous silica nanoparticles from Slowing et al. 2007 [63], (c) hollow silica nanoparticles from Deng et al. 2011 [64], (d) single walled CNTs from Kam and Dai 2005 [65], and (e) gold nanoparticles from Tiwari et al. 2014 [66].